AXIM BIOTECHNOLOGIES, INC. (15)

Browse by Contract Category

Contracts

Binding Term Sheet Agreement dated August 3, 2021, by and between AXIM Biotechnologies, Inc. and Advanced Tear Diagnostics, LLC (Filed With SEC on April 15, 2022)
Description of Securities (Filed With SEC on April 15, 2022)
Termination Agreement dated March 3, 2022, by and between AXIM Biotechnologies, Inc. and Empowered Diagnostics, LLC (Filed With SEC on April 15, 2022)
Asset Purchase Agreement dated August 26, 2021, by and between AXIM Biotechnologies, Inc. and Advanced Tear Diagnostics, LLC (Filed With SEC on April 15, 2022)
PROMISSORY NOTE (Filed With SEC on February 16, 2022)
CONVERTIBLE NOTE (Filed With SEC on February 16, 2022)
AXIM BIOTECHNOLOGIES, INC. 6% CONVERTIBLE REDEEMABLE NOTE DUE SEPTEMBER 29, 2022 (Filed With SEC on February 16, 2022)
EQUITY PURCHASE AGREEMENT (Filed With SEC on May 14, 2021)
EQUITY PURCHASE AGREEMENT (Filed With SEC on May 14, 2021)
(Filed With SEC on May 14, 2020)
(Filed With SEC on March 19, 2020)
(Filed With SEC on March 19, 2020)
(Filed With SEC on January 8, 2020)
AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT (Filed With SEC on December 17, 2019)
PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on February 26, 2019)